Table 3.

Excess Hazard Ratios for Death Among Patients Diagnosed With Ovarian Cancer for Stage I and Stage III–IV as a Function of Age at Diagnosis by Year Since Diagnosis Adjusting for Race, Age, Year of Diagnosis, and Year Since Diagnosis

Age Group	Stage I	Stage III–IV
1-y excess HR
Age at diagnosis (y)
Younger than 20 relative to 50–59	0.37 (0.15–0.92)	0.34 (0.18–0.63)
20–49 relative to 50–59	0.73 (0.55–0.96)	0.74 (0.66–0.82)
60–69 relative to 50–59	1.02 (0.73–1.43)	1.31 (1.20–1.43)
70–79 relative to 50–59	1.34 (0.91–1.96)	1.80 (1.65–1.97)
80 or older relative to 50–59	3.41 (2.33–5.01)	2.71 (2.45–2.98)
5-y excess HR
Age at diagnosis (y)
Younger than 20 relative to 50–59	0.08 (0.01–0.78)	—*
20–49 relative to 50–59	0.43 (0.20–0.94)	0.58 (0.37–0.91)
60–69 relative to 50–59	1.09 (0.44–2.67)	1.23 (0.83–1.82)
70–79 relative to 50–59	1.03 (0.28–3.72)	2.75 (1.78–4.27)
80 or older relative to 50–59	—*	6.40 (2.90–14.14)
10-y excess HR
Age at diagnosis (y)
Younger than 20 relative to 50–59	1.10 (0.04–27.31)	—*
20–49 relative to 50–59	1.74 (0.81–3.71)	0.91 (0.50–1.62)
60–69 relative to 50–59	0.57 (0.23–1.40)	1.91 (1.07–3.39)
70–79 relative to 50–59	1.22 (0.22–6.72)	0.72 (0.29–1.80)
80 or older relative to 50–59	—*	0.87 (0.05–14.48)

HR, hazard ratio.

Data are HR (95% confidence interval).

Bold indicates P<.05.

^*Estimates are not computed as a result of the small number of deaths in each 1-year interval.